Volpi Connor, Shehadeh Fadi, Mylonakis Eleftherios
Brown University School of Public Health.
Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI.
Medicine (Baltimore). 2020 Feb;99(9):e19271. doi: 10.1097/MD.0000000000019271.
The objective of this study was to examine the association between county-level socioeconomic factors and brand-name drug prescription drug patterns among medical specialties with overall high brand-name outpatient prescription use.This cross-sectional study used data from 2 publicly available datasets. The 2015 Medicare Part D PUF data quantifies the prescription rates at the county-level and data from the US Census Bureau provides information on socioeconomic status at the county-level.We analyzed 3,821,523 brand-name claims and 14,088,613 generic claims reported by health providers from 40 specialties as provided by the 2015 Medicare Part D dataset. Internal Medicine, Family Practice, General Practice, Cardiology, and Ophthalmology accounted for 71% of the total amount of brand-name drugs filled under Medicare Part D in 2015. As the presence of individuals with an income ≥$100,000 increased in a given county, the likelihood of receiving a brand-name prescription claim increased.A county-level association exists involving socioeconomic factors and outpatient brand-name drug prescription patterns. Future interventions should consider these factors in order to reduce percentage of brand-name drugs filled and decrease health care expenditures.
本研究的目的是在总体门诊品牌药处方使用率较高的医学专科中,考察县级社会经济因素与品牌药处方药模式之间的关联。这项横断面研究使用了两个公开可用数据集的数据。2015年医疗保险D部分的药房使用文件(PUF)数据量化了县级的处方率,而美国人口普查局的数据提供了县级社会经济状况的信息。我们分析了2015年医疗保险D部分数据集中40个专科的医疗服务提供者报告的3,821,523份品牌药索赔和14,088,613份非专利药索赔。内科、家庭医学、普通科、心脏病学和眼科占2015年医疗保险D部分所配品牌药总量的71%。在某一特定县,收入≥10万美元的人群数量增加时,收到品牌药处方索赔的可能性也会增加。县级社会经济因素与门诊品牌药处方模式之间存在关联。未来的干预措施应考虑这些因素,以降低品牌药的配药比例并减少医疗保健支出。